Interview with Vicki St Quintin, COO, PIASA. Pharmaceutical Industry Association…
South Africa has recently achieved the 1st Millennium Development Goal (MDG) – reducing the proportion of the…
Address: Thornhill Office Park, Building No 5, 94 Bekker Street
Vorna Valley 1686, South Africa ,South Africa
Tel: +27 11 805 51 00
Web: http://www.piasa.co.za/default.asp
The Pharmaceutical Industry Association of South Africa (PIASA) is a trade association of companies involved in the manufacture and/or marketing of prescription medicines in South Africa.
Membership is voluntary and includes a broad representation of foreign multinational pharmaceutical companies and local companies, both large and small. PIASA currently represents approximately 33% of the total private sector pharmaceutical market in South Africa.
The members of PIASA aim to bring the best medicines to the South African market. PIASA companies are important members of the South African business community, marketing medicines, including both innovative and generic medicines, to the health professions. In addition to promoting and safeguarding the interests of members PIASA provides a service to the public as well as the general medical and healthcare community.
Mission
To sustain a favourable environment for the continued development of the pharmaceutical industry in South Africa as it strives to increase access to quality medicines, with the ultimate aim of saving lives and improving the quality of life for all South Africans
Values
Members of PIASA subscribe to the following values:
Respect for intellectual property rights
Commitment to good corporate governance
Commitment to the Code of Marketing Practice
Adherence to best practice in manufacturing, clinical research, distribution and regulatory affairs.
Profile
Pharmaceutical trade organisation – voluntary membership.
Members comprise research based multinational, local/generic and empowerment pharmaceutical companies operating in SA.
18 members
32% Private Sector Market Share
Represents South Africa internationally as a member of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).
association
South Africa has recently achieved the 1st Millennium Development Goal (MDG) – reducing the proportion of the…
South African firm Aspen has inked a deal with Johnson & Johnson for the technical transfer and proposed…
As COVID-19 threatens to derail more than a decade’s worth of hard-won gains in the fight against malaria, Dr…
The South African affiliate of Indian pharma firm Cipla will begin manufacturing and distribution of remdesivir, a…
Below is a roundup of latest news from South Africa’s life sciences and healthcare industries, including a…
Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a registered NPO born out of necessity when…
Trailing behind South Africa’s pharmaceutical market in both value and growth, the nation’s medical device…
The traditional model of healthcare has generally been limited to treatment in health facilities. But, when it…
Eclectic demographics, rapid patient recruitment, and a burgeoning population with a gradient of disease…
While South Africa faces a distinct set of challenges in effectively managing its healthcare sector, the ecosystem…
Hersol prides itself on producing high-quality products and is today one of the leading Pharmaceutical Contract…
Albert Denoon (AB) and Jeff Hampton (JH) illustrate how the Crossroads and Campbell Institutes, two non-profit…
The general manager of Bard SA, Charl De Klerk, illustrates the company’s growth ambitions within South Africa…